| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-07 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.21 | 7e-07 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.18 | 9e-07 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.19 | 1e-06 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.21 | 1e-06 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.17 | 2e-06 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.26 | 2e-06 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-06 |